Hideya Inoue

Director, Clinical Research & Development Division
Deputy head of Neuroscience Business Unit

Hideya Inoue

Capable of conducting clinical trials with a high degree of difficulty

Capable of conducting clinical trials with a high degree of difficulty

Currently, Linical is mainly engaged in the areas of oncology and CNS (Central Nervous System), but when the company was first established, our main business was in other primary areas. We were awarded numerous contracts for difficult kinds of clinical trials for immune disorders like inflammatory intestinal disease, in part because many of the founding members of Linical had been involved in the development of immunosuppressant drugs at pharmaceutical companies. All of the products we conducted clinical trials in, ended up on the market, and we accumulated a wealth of experience and built ourselves a strong track record.
Many of the people who worked on these difficult clinical trials in the first years of Linical’s operation, are now actively serving in important roles such as monitor leaders (MLs) in various areas, currently supporting the company’s efforts in the areas of oncology, CNS diseases, and primary diseases. Thanks to these highly experienced and proven MLs, Linical is capable of conducting clinical trials with a high degree of difficulty. Thus, we can deliver high-quality management of clinical trials in any therapeutic area.

In recent years, demand for global services has been growing in primary areas too, so the difficulty of clinical trials is increasing day by day. If you require experience and expertise in these challenging trials, Linical can provide the management needed to lead you to success, so please feel free to contact us for a consultation.